177 related articles for article (PubMed ID: 37834342)
1. β-Lactam TRPM8 Antagonists Derived from Phe-Phenylalaninol Conjugates: Structure-Activity Relationships and Antiallodynic Activity.
Martín-Escura C; Bonache MÁ; Medina JA; Medina-Peris A; De Andrés-López J; González-Rodríguez S; Kerselaers S; Fernández-Ballester G; Voets T; Ferrer-Montiel A; Fernández-Carvajal A; González-Muñiz R
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834342
[TBL] [Abstract][Full Text] [Related]
2. Phenylalanine-Derived β-Lactam TRPM8 Modulators. Configuration Effect on the Antagonist Activity.
Bonache MÁ; Llabrés PJ; Martín-Escura C; De la Torre-Martínez R; Medina-Peris A; Butrón L; Gómez-Monterrey I; Roa AM; Fernández-Ballester G; Ferrer-Montiel A; Fernández-Carvajal A; González-Muñiz R
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33673444
[TBL] [Abstract][Full Text] [Related]
3. Highly functionalized β-lactams and 2-ketopiperazines as TRPM8 antagonists with antiallodynic activity.
Bonache MÁ; Martín-Escura C; de la Torre Martínez R; Medina A; González-Rodríguez S; Francesch A; Cuevas C; Roa AM; Fernández-Ballester G; Ferrer-Montiel A; Fernández-Carvajal A; González-Muñiz R
Sci Rep; 2020 Aug; 10(1):14154. PubMed ID: 32843690
[TBL] [Abstract][Full Text] [Related]
4. Antinociceptive activity of transient receptor potential channel TRPV1, TRPA1, and TRPM8 antagonists in neurogenic and neuropathic pain models in mice.
Sałat K; Filipek B
J Zhejiang Univ Sci B; 2015 Mar; 16(3):167-78. PubMed ID: 25743118
[TBL] [Abstract][Full Text] [Related]
5. Structure-Based Design of Novel Biphenyl Amide Antagonists of Human Transient Receptor Potential Cation Channel Subfamily M Member 8 Channels with Potential Implications in the Treatment of Sensory Neuropathies.
Journigan VB; Feng Z; Rahman S; Wang Y; Amin ARMR; Heffner CE; Bachtel N; Wang S; Gonzalez-Rodriguez S; Fernández-Carvajal A; Fernández-Ballester G; Hilton JK; Van Horn WD; Ferrer-Montiel A; Xie XQ; Rahman T
ACS Chem Neurosci; 2020 Feb; 11(3):268-290. PubMed ID: 31850745
[TBL] [Abstract][Full Text] [Related]
6. β-Lactam TRPM8 Antagonist RGM8-51 Displays Antinociceptive Activity in Different Animal Models.
Martín-Escura C; Medina-Peris A; Spear LA; de la Torre Martínez R; Olivos-Oré LA; Barahona MV; González-Rodríguez S; Fernández-Ballester G; Fernández-Carvajal A; Artalejo AR; Ferrer-Montiel A; González-Muñiz R
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269831
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and optimization of novel α-phenylglycinamides as selective TRPM8 antagonists.
Kobayashi JI; Hirasawa H; Ozawa T; Ozawa T; Takeda H; Fujimori Y; Nakanishi O; Kamada N; Ikeda T
Bioorg Med Chem; 2017 Jan; 25(2):727-742. PubMed ID: 27964995
[TBL] [Abstract][Full Text] [Related]
8. Ion channel mechanisms of rat tail artery contraction-relaxation by menthol involving, respectively, TRPM8 activation and L-type Ca2+ channel inhibition.
Melanaphy D; Johnson CD; Kustov MV; Watson CA; Borysova L; Burdyga TV; Zholos AV
Am J Physiol Heart Circ Physiol; 2016 Dec; 311(6):H1416-H1430. PubMed ID: 27765744
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological blockade of TRPM8 ion channels alters cold and cold pain responses in mice.
Knowlton WM; Daniels RL; Palkar R; McCoy DD; McKemy DD
PLoS One; 2011; 6(9):e25894. PubMed ID: 21984952
[TBL] [Abstract][Full Text] [Related]
10. Characterization of selective TRPM8 ligands and their structure activity response (S.A.R) relationship.
Sherkheli MA; Vogt-Eisele AK; Bura D; Beltrán Márques LR; Gisselmann G; Hatt H
J Pharm Pharm Sci; 2010; 13(2):242-53. PubMed ID: 20816009
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, high-throughput screening and pharmacological characterization of β-lactam derivatives as TRPM8 antagonists.
de la Torre-Martínez R; Bonache MA; Llabrés-Campaner PJ; Balsera B; Fernández-Carvajal A; Fernández-Ballester G; Ferrer-Montiel A; Pérez de Vega MJ; González-Muñiz R
Sci Rep; 2017 Sep; 7(1):10766. PubMed ID: 28883526
[TBL] [Abstract][Full Text] [Related]
12. Menthol derivative WS-12 selectively activates transient receptor potential melastatin-8 (TRPM8) ion channels.
Ma S; G G; Ak VE; Jf D; H H
Pak J Pharm Sci; 2008 Oct; 21(4):370-8. PubMed ID: 18930858
[TBL] [Abstract][Full Text] [Related]
13. Exploration of TRPM8 Binding Sites by β-Carboline-Based Antagonists and Their In Vitro Characterization and In Vivo Analgesic Activities.
Bertamino A; Ostacolo C; Medina A; Di Sarno V; Lauro G; Ciaglia T; Vestuto V; Pepe G; Basilicata MG; Musella S; Smaldone G; Cristiano C; Gonzalez-Rodriguez S; Fernandez-Carvajal A; Bifulco G; Campiglia P; Gomez-Monterrey I; Russo R
J Med Chem; 2020 Sep; 63(17):9672-9694. PubMed ID: 32787109
[TBL] [Abstract][Full Text] [Related]
14. Human TRPM8 and TRPA1 pain channels, including a gene variant with increased sensitivity to agonists (TRPA1 R797T), exhibit differential regulation by SRC-tyrosine kinase inhibitor.
Morgan K; Sadofsky LR; Crow C; Morice AH
Biosci Rep; 2014 Aug; 34(4):. PubMed ID: 24975826
[TBL] [Abstract][Full Text] [Related]
15. TRPM8 channel inhibitor AMTB suppresses murine T-cell activation induced by T-cell receptor stimulation, concanavalin A, or external antigen re-stimulation.
Kume H; Tsukimoto M
Biochem Biophys Res Commun; 2019 Feb; 509(4):918-924. PubMed ID: 30642628
[TBL] [Abstract][Full Text] [Related]
16. Isoxazole derivatives as potent transient receptor potential melastatin type 8 (TRPM8) agonists.
Ostacolo C; Ambrosino P; Russo R; Lo Monte M; Soldovieri MV; Laneri S; Sacchi A; Vistoli G; Taglialatela M; Calignano A
Eur J Med Chem; 2013 Nov; 69():659-69. PubMed ID: 24095758
[TBL] [Abstract][Full Text] [Related]
17. Tryptamine-Based Derivatives as Transient Receptor Potential Melastatin Type 8 (TRPM8) Channel Modulators.
Bertamino A; Ostacolo C; Ambrosino P; Musella S; Di Sarno V; Ciaglia T; Soldovieri MV; Iraci N; Fernandez Carvajal A; de la Torre-Martinez R; Ferrer-Montiel A; Gonzalez Muniz R; Novellino E; Taglialatela M; Campiglia P; Gomez-Monterrey I
J Med Chem; 2016 Mar; 59(5):2179-91. PubMed ID: 26847872
[TBL] [Abstract][Full Text] [Related]
18. The contribution of TRPM8 and TRPA1 channels to cold allodynia and neuropathic pain.
Caspani O; Zurborg S; Labuz D; Heppenstall PA
PLoS One; 2009 Oct; 4(10):e7383. PubMed ID: 19812688
[TBL] [Abstract][Full Text] [Related]
19. Identification of a Potent Tryptophan-Based TRPM8 Antagonist With in Vivo Analgesic Activity.
Bertamino A; Iraci N; Ostacolo C; Ambrosino P; Musella S; Di Sarno V; Ciaglia T; Pepe G; Sala M; Soldovieri MV; Mosca I; Gonzalez-Rodriguez S; Fernandez-Carvajal A; Ferrer-Montiel A; Novellino E; Taglialatela M; Campiglia P; Gomez-Monterrey I
J Med Chem; 2018 Jul; 61(14):6140-6152. PubMed ID: 29939028
[TBL] [Abstract][Full Text] [Related]
20. Rational Design of a Modality-Specific Inhibitor of TRPM8 Channel against Oxaliplatin-Induced Cold Allodynia.
Aierken A; Xie YK; Dong W; Apaer A; Lin JJ; Zhao Z; Yang S; Xu ZZ; Yang F
Adv Sci (Weinh); 2021 Nov; 8(22):e2101717. PubMed ID: 34658162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
